CORZQ — Core Scientific Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeSmall CapNeutral
- $110.76m
- $1.13bn
- $544.48m
Annual cashflow statement for Core Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -11.9 | -12.2 | 47.3 |
| Depreciation | |||
| Non-Cash Items | -1.2 | 0.161 | -87.9 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 6.17 | -21.1 | -49.5 |
| Change in Accounts Receivable | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Net Change in Other Assets & Liabilities | |||
| Cash from Operating Activities | -0.832 | -23.8 | -56.7 |
| Capital Expenditures | -37.5 | -15.2 | -424 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 0.16 | 0.092 | 0.645 |
| Sale of Business | |||
| Sale of Fixed Assets | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -37.4 | -15.1 | -424 |
| Financing Cash Flow Items | — | — | -10.7 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 28.7 | 40.7 | 604 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -9.5 | 1.81 | 123 |